The FDA announced that it was adding safety warnings to the labels of medications that are intended to treat type 2 diabates and contain saxagliptin and alogliptin. An FDA safety review found the drugs might increase the risk of heart failure in some patients, particularly those with known heart or kidney disease.

American College of Cardiology president, Kim Williams Sr., MD, called for the cardiology community to refocus efforts on heart disease prevention, rather than treatment alone, in his opening statements at the 65th Annual Scientific Session & Expo of the ACC in Chicago.

Richard Chazal, MD, FACC, assumed the role as President of the American College of Cardiology (ACC) during the ACC’s annual scientific session in Chicago on April 4.

Los Altos, CA – March 31, 2016:ScImage will launch PicomSentry, a preconfigured appliance that enables users to utilize ScImage’s PICOM365 Enterprise PACS with plug and play convenience, at the upcoming ACC.16, the 65th Annual Scientific Session & Expo of the American College of Cardiology (ACC), April 2-4, 2016 in Chicago. (Booth 20076)

A report from the Centers for Medicare and Medicaid Services found that proprietary blood testing devices from Theranos often failed to meet the company’s accuracy standards, the Wall Street Journal reports. According to the report, 29 percent of the quality-control checks were outside the range that Theranos considered acceptable.

The guidelines were published online in the Journal of the American College of Cardiology and Circulation.

The American College of Cardiology (ACC) announced that five young researchers had received research awards for training and development.

Randomized clinical trials of interventional cardiology devices with industry-employee authors were significantly more likely to report favorable findings compared with randomized trials that did not have industry-employee authors, according to an analysis of prospective studies.